共 27 条
[4]
FORSSEN EA, 1992, CANCER RES, V52, P3255
[5]
US Food and Drug Administration approval: Panitumumab for epidermal growth factor receptor-expressing metestetic colorectal carcinoma with progression following fluropyrimidine-, oxelipletin-, and irinotecen-containing chemotherapy regimens
[J].
CLINICAL CANCER RESEARCH,
2008, 14 (05)
:1296-1302